VerifiedRx

By Vizient Center for Pharmacy Practice ExcellenceBusiness Science Medicine Health & Fitness Management

VerifiedRx episodes

October 13Advancing access to cell and gene therapies through the Advanced Therapeutics Alliance
Advanced therapeutics are expanding treatment possibilities for patients while creating new operational, financial and access challenges for health systems. Host Carolyn Liptak joins Elizabeth Oyekan, Lynn Eschenbacher and Carina Dolan to discuss the Advanced Therapeutics Alliance, a provider-led collaborative that brings together healthcare providers, payers, pharmaceutical companies and other industry partners to improve access to cell and gene therapies through shared knowledge, coordinated action and cross-sector collaboration.
To join the alliance, visit Advanced Therapeutics Alliance.

Guest Speakers:
Elizabeth Oyekan, PharmD, FCSHP, CPHQ, CPEL
President
FiveTwo Health Partners

Lynn Eschenbacher, PharmD, MBA, FASHP, CPEL
Chief Pharmacy Officer and Strategy Officer
PharmaForce

Carina Dolan, PharmD, MS Pharm, BCOP
AVP, Market Insights & Forecasting
Vizient Clinical Spend Management

Host:
Carolyn Liptak, MBA, BS Pharm
Pharmacy Executive Director, Regulatory Compliance
Vizient Center for Pharmacy Practice Excellence

Show Notes:
[01:07]
How fragmented systems can create delays for patients
The development of the Advanced Therapeutics Alliance and its focus on access, sustainability, and equity
[02:40]
The challenges created by single case agreements, payer requirements, and manual processes
The value of health systems sharing solutions instead of addressing similar challenges independently
[04:14]
Common concerns across health systems related to reimbursement, infrastructure, patient access, payer variability, and long term sustainability
The importance of connecting organizations that are facing similar challenges
Why improving access to advanced therapies requires collaboration across the healthcare ecosystem
[06:06]
Pharmacy’s role across clinical care, operations, finance, regulatory requirements, and patient support
The importance of involving pharmacy leaders early in the development
Opportunity for pharmacy to help lead this work while bringing the right partners to the table
[08:48]
The need for collaboration among pharmacy, physicians, nursing, finance, revenue cycle, administration, manufacturers, payers, and patient advocacy organizations
How pharmacy leaders are helping their organizations establish the policies, resources, and processes needed to support advanced therapies
The Alliance’s role in extending collaboration beyond individual health systems
[10:33]
What distinguishes the Advanced Therapeutics Alliance from other efforts in this space
The focus on turning shared experiences into practical action
[11:23]
How greater understanding across the healthcare ecosystem can support scalable and sustainable processes
The role of Vizient in connecting providers, manufacturers, payers, and other partners
[12:26]
How organizations can bring forward their priorities, experiences, challenges, and ideas
The goal of translating existing knowledge into action that can be shared across organizations
[13:05]
The Alliance’s mission to increase patient access to life changing therapies
The need to build sustainable processes that can support the growing number of advanced therapies
[14:48]
The value of joining the Alliance while its work groups and resources are being established
How pharmacy leaders can learn from peers and bring new perspectives back to their organizations
[16:32]
The importance of sharing real world experiences and contributing to collaborative solutions
The call for stakeholders across the cell and gene therapy ecosystem to help improve access and sustainability for patients

Links and Resources:
Advanced Therapeutics Alliance
Vizient Cell & Gene Therapy
Advancing cell, gene, and specialty therapies requires enterprise transformation, Jun 18, 2026.
For more information: Vizient pharmacy questions mailbox

Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed
19 min
September 29Don't set it and forget it: Managing biosimilar formularies dynamically
Strategic biosimilar optimization can help health systems evaluate medication choices through a broader clinical, operational, financial, and payer-focused lens. Dr. Jerry Rebo from Novant Health joins host Heather Pace to discuss a structured quarterly process for reviewing biosimilar performance, monitoring payer preferences, identifying denial trends, and supporting informed therapy decisions. He shares practical guidance for health systems, building a similar approach with existing resources.

Guest:
Jerry Rebo, PharmD, MBA, BCPS, BCCCPS, D-PLA
Director of Value & Outcomes
Novant Health
Host:
Heather Pace, PharmD
Senior Clinical Manager, Ambulatory
Center for Pharmacy Practice Excellence, Clinical Spend Management
Vizient

Show Notes:
[00:55]
The challenges of managing biosimilars across clinical care, clinic operations, reimbursement, payer contracting, prior authorization, and patient experience.
The factors Novant Health considers when evaluating biosimilar products and therapeutic classes.
[01:51]
Novant Health’s structured four-week review process, beginning with data collection from studies, reimbursement reports, payer policies, denial trends, and margin analysis.
The role of therapeutic class reviews, clinical feedback, operational considerations, and financial performance in developing quarterly recommendations.
[03:27]
The purpose of a biosimilar payer table and the way it tracks formulary updates, payer preferences, documentation requirements, and denial trends.
How payer information supports communication among medical teams, authorization teams, pharmacy teams, and informatics partners.
[04:52]
The difference between responding to individual denials and monitoring denial patterns over time.
The value of identifying whether denials are connected to internal operational issues or changes in payer policies and plans.
[06:49]
How expected payment rates are calculated by comparing actual reimbursement with billed amounts.
The importance of reviewing reimbursement performance regularly so product recommendations can be updated as conditions change.
[07:56]
The challenges of identifying opportunities for optimization across different therapeutic classes and payer types.
Why Medicare Advantage plans require additional review since their preferences may differ from standard Medicare formularies.
[09:36]
The value of breaking down organizational silos and bringing pharmacy, revenue cycle, clinical, operational, and administrative experts together.
How a systematic biosimilar review process may support future medication management efforts involving biologics, cell therapies, and gene therapies.
[10:53]
Practical advice for health systems that want to begin a biosimilar optimization process with limited resources or staffing.
The importance of connecting with colleagues, learning from related initiatives, and mapping existing workflows before building a new process.
[12:02]
Opportunities to use automation and technology to reduce manual data preparation.
The potential for more efficient tools to give teams additional time for analysis, recommendations, and implementation.
[13:16]
The importance of building relationships across the health system to solve shared problems.
The role of cross-functional collaboration in supporting successful biosimilar management.
Links and Resources:
Vizient 2026 Connections Summit (poster presentations will be available for viewing on Oct 7)

Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed
15 min
September 15 2026 Joint Commission Medication Management Update
Medication management remains a critical focus for accreditation, quality, and patient safety. This episode features highlights from a recent Vizient and Joint Commission live broadcast exploring updated medication management standards, National Patient Safety Goals, and key survey observations affecting healthcare organizations today. Dr. Robert Campbell from Joint Commission and Diana Scott from Vizient join host Carolyn Liptak to discuss why standards evolve, emerging areas of risk, and practical insights to help organizations strengthen safe, high-quality care.
Guest speakers:
Robert Campbell, PharmD, BCSCP
Vice President, Accreditation/Certification Program Development and Accreditation Management
Medication Safety Division of Accreditation and Certification Operations
Joint Commission

Diana Scott, MHA, RN, CPHQ
Principal, Regulatory and Accreditation Services
Vizient
Host: 
Carolyn Liptak, MBA, BS Pharm 
Pharmacy Executive Director, Regulatory Compliance 
Vizient Center for Pharmacy Practice Excellence

Show Notes:
[01:09] Updates to the Joint Commission standards and the focus on relevance, usefulness, and patient safety.
[02:13] Joint Commission replaced national patient safety goals with national performance goals. How medication management connects to other goals involving patient identification, care delivery, and health professional resource management.
[03:22] Looking beyond the number of findings to evaluate their potential impact, degree, and scope. A single observation can reveal a significant system or process failure requiring immediate attention.
[04:05] Multiple observations may now be grouped under one requirement for improvement, but each observation still requires correction.
[04:55] The three criteria used to identify an immediate threat to health or safety and taking action as soon as potential risks are identified during a survey.
[06:06] The difference between mitigation and abatement when addressing an immediate threat to health or safety.
[07:04] Situations in which Joint Commission may return within 23 calendar days to evaluate whether an issue has been corrected.
[07:38] Common concerns with titrated medications, including documentation that does not align with the most recent medication order.
[09:03] Medication safety responsibilities that extend across pharmacy, nursing, prescribers, procedural areas, and other departments.
[09:32] Sterile compounding concerns involving aseptic technique, hygiene, personal protective equipment, and environmental conditions.
[10:20] Immediate use compounding and the importance of distinguishing it from other preparation activities.
[10:46] Labeling medications and solutions in syringes, basins, bowls, cups, and other containers in procedural areas.
[11:18] Proper labeling as a simple but essential safeguard in fast-moving care environments.
[11:24] Medication management is a complex system that requires collaboration across multiple departments.
[12:11] Looking beyond requirement for improvement counts to evaluate the risks and scope behind each finding.

Links and Resources:
Joint Commission Medication Management Update 2026 – Vizient On Demand Webinar
Joint Commission Standards and Elements of Performance: Medication Management

Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed

14 min
August 25Oral Arguments: Enlicitide, the first oral PCSK9 inhibitor for dyslipidemia
Cardiovascular disease remains a leading cause of death, while evolving guidelines and increasingly aggressive LDL cholesterol targets are changing how clinicians approach lipid management. Jodi Martinez, Pharmacist Clinical Specialist in Cardiology at the University of Colorado Hospital, part of UCHealth, joins Kerry Schwarz, Senior Clinical Manager for Evidence Based Medicine and Outcomes with the Vizient Center for Pharmacy Practice Excellence, to explore the emerging role of enlicitide in lipid management. They discuss the evidence behind its approval, its potential to expand patient access and where this first oral PCSK9 inhibitor may fit alongside existing therapies.

Guest Speaker:
Dr. Jodi Martinez, Pharm.D., BCPS, BCCP, HF-CERT
Pharmacist Clinical Specialist in Cardiology
University of Colorado Hospital, UCHealth

Host:
Dr. Kerry Schwarz, Pharm.D., MPH
Senior Clinical Manager, Evidence-Based Medicine and Outcomes
Vizient Center for Pharmacy Practice Excellence 

Show Notes:
[01:26]
The limitations of current lipid management and why many high-risk patients still struggle to reach increasingly aggressive LDL cholesterol targets.
How cost, prior authorization requirements and step therapy can create barriers to accessing injectable PCSK9 therapies.
[03:27]
The evidence behind enlicitide and findings from the CORALreef clinical trial supporting its FDA approval.
How enlicitide performed across LDL cholesterol, non-HDL cholesterol, ApoB and lipoprotein(a) endpoints, and why cardiovascular outcomes remain an important unanswered question.
[06:37]
An oral PCSK9 inhibitor could expand access by offering an alternative to specialty injectable therapies.
Why retail pharmacy availability, cost and greater prescribing flexibility could help more patients receive intensive lipid lowering therapy.
[08:11]
The potential barriers to enlicitide adoption, including delays in formulary review, insurance coverage and the administrative burden placed on clinicians.
The lack of published cardiovascular outcomes could influence payer coverage, formulary placement and early uptake.
[10:15]
Station remains the cornerstone of lipid management and where enlicitide may ultimately play a role
Clinicians may consider the amount of LDL reduction a patient needs when choosing among available therapies.

Links and Resources:
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed
13 min
August 11More than a building: the business case for consolidated pharmacy services centers
One of the most difficult—and least discussed—aspects of building a Consolidated Service Center (CSC) is securing executive support and capital investment. Success depends on connecting strategy, financial value and patient outcomes to an organization's broader goals. Ganesh Chandran is joined by Dr. Akeem Bale, Vice President, Pharmacy Services at the University of Texas Medical Branch, and Dr. Laura Mark, Vice President of Pharmacy at Allegheny Health Network, to discuss the strategic, financial, and organizational steps that transformed a promising idea into an approved capital investment.
Guest Speakers:
Akeem O. Bale, PharmD, MS, MBA, BCPS, BCSCP
Vice President, Pharmacy Services
Program Director, PGY1/2 HSPAL Residency Program
UTMB Health, Department of Pharmacy Services
Laura Mark, MS, MHM, PharmD
Vice President of Pharmacy
Allegheny Health Network

Host:  
Ganesh Chandran, PharmD, MBA
Pharmacy Executive
Vizient Pharmacy Enterprise Support

Show notes:
[01:12]
How each organization recognized that traditional pharmacy operations could no longer support future growth, expanding ambulatory care, and increasing operational complexity.
Why long-term strategic planning, workforce challenges, and enterprise wide support became the driving forces behind pursuing a consolidated service center.
[04:39]
How successful business cases focus on organizational priorities such as patient access, financial performance, quality outcomes, and total cost of care instead of technology alone.
Why demonstrating measurable value through pilots, standardization, and return on investment helps gain executive support for large scale transformation.
[08:30]
The importance of tailoring proposals to different executive stakeholders while building champions who can advocate for the vision.
How early operational improvements and phased implementation can demonstrate value before construction or major capital investments begin.
[10:24]
Why breaking a consolidated service center strategy into manageable phases creates confidence among executive leaders and improves long term success.
How responding to executive questions with refined financial models and scenario planning strengthens both the proposal and organizational trust.
[13:12]
How creating an enterprise wide pharmacy culture through standardization, trust, and shared leadership prepares teams for organizational change.
Why establishing a one team philosophy before opening a new facility creates stronger collaboration and more sustainable operational success.
[16:56]
Practical advice for pharmacy leaders beginning their own consolidated service center journey, including learning from peer organizations and celebrating incremental progress.
Why a consolidated service center should be viewed as an enabler of a broader pharmacy strategy that supports long term growth, scalability, and patient care rather than simply a new building.

Links and Resources: Pharmacy Enterprise Support

Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed
21 min
July 28Insights from the Summer 2026 Spend Management Outlook
Updated inflation projections are only part of the story when it comes to pharmacy planning. Host Carolyn Liptak is joined by Dr. Jeni Hayes and Dr. Amanda Frick, to discuss Vizient’s Summer 2026 Spend Management Outlook and why utilization trends, reimbursement, ambulatory care, and the expanding pipeline of advanced therapies are becoming just as important as inflation when preparing health systems for 2027 and beyond.

Guest speakers:
Jeni Hayes, PharmD, MS Pharm, BCPS
Senior Clinical Manager, Market Insights & Forecasting
Vizient Clinical Spend Management

Amanda Frick, PharmD, BCPS
Senior Clinical Manager, Market Insights and Forecasting
Vizient Clinical Spend Management

Host:  
Carolyn Liptak, MBA, BS Pharm
Pharmacy Executive Director, Regulatory Compliance
Vizient Center for Pharmacy Practice Excellence  

Show notes:
01:03
Why this year's Spend Management Outlook expands beyond inflation to include utilization, reimbursement, product mix, and operational readiness.
How pharmacy leaders can use these broader market signals to make stronger strategic and financial decisions.
01:54
The updated 2027 pharmaceutical inflation projection and why it increased from the previous forecast.
Why organizations should pair national benchmarks with their own purchasing data to improve budgeting accuracy.
03:28
Three major trends transforming pharmacy planning, including ambulatory growth, utilization, and enterprise collaboration.
Why these consistent themes are changing how health systems approach long term pharmacy strategy.
04:25
How new utilization analyses provide earlier insight into future pharmacy demand than inflation data alone.
Examples of shifting trends in oncology therapies and GLP 1 medications that are influencing operational planning.
05:34
Why GLP 1 growth is creating opportunities that extend well beyond pharmacy budgeting.
How retail pharmacy, specialty pharmacy, pharmacist led clinics, and medication management can strengthen patient care and organizational performance.
07:10
Why pharmacy has evolved into an enterprise wide capability that impacts access, reimbursement, and financial performance.
How stronger collaboration across pharmacy, finance, revenue cycle, and clinical teams supports future readiness.
08:03
Emerging pipeline trends, including continued oncology growth and the rise of advanced therapies.
Why cell therapies, gene therapies, and RNA based medicines require organizations to prepare differently than traditional medications.
08:53
How health systems are preparing months before therapy approval by building operational and clinical infrastructure.
Why advanced therapies demand coordination across pharmacy, laboratory, nursing, finance, and physician teams.
10:33
The expansion of advanced therapies into autoimmune, neurologic, cardiac, and rare disease treatment.
Why organizations must balance planning for both high cost therapies and therapies with growing patient demand.
11:44
How pipeline monitoring has evolved into a strategic planning tool rather than simply tracking approvals.
Why early preparation helps organizations identify operational gaps before new therapies reach the market.
12:36
Key takeaways on preparing for the future of pharmacy through utilization data, operational planning, and enterprise collaboration.
Resources available through the Spend Management Outlook Insights Hub to support local budgeting and long term strategy.

Links and Resources:
Vizient Spend Management Outlook Insight Hub

Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed
15 min
July 14More than a brand: Strategic botulinum toxin decisions
Botulinum toxin products are used across a wide range of therapeutic indications, yet many health systems have not evaluated whether product selection aligns with both clinical evidence and financial stewardship. Matt Groth, Director of Pharmacy and Pharmaceutical Supply Chain Management at the University of Rochester Medical Center, joins Kerry Schwarz to discuss how his team implemented a botulinum toxin stewardship strategy by evaluating evidence, engaging clinicians, and standardizing product selection.

Guest Speaker:
Matthew D. Groth, PharmD, MS
Director of Pharmacy
Pharmaceutical Supply Chain Management
University of Rochester Medical Center

Host:
Dr. Kerry Schwarz, Pharm.D., MPH
Senior Clinical Manager, Evidence-Based Medicine and Outcomes
Vizient Center for Pharmacy Practice Excellence 

Show Notes:
00:05 Introduction
Learn why botulinum toxin stewardship is an emerging opportunity for health systems.
Hear how clinical evidence and financial strategy can work together to optimize product selection.
01:25 Reviewing the evidence
Explore the evidence supporting available botulinum toxin products, including indications, safety, and dosing considerations.
Understand why limited clinical differences between products create opportunities for formulary evaluation.
02:31 Identifying stewardship opportunities
Learn how organizations evaluate acquisition costs, reimbursement, payer policies, and contracting opportunities.
Discover how financial analysis helps identify opportunities to reduce costs while maintaining quality patient care.
04:29 Implementing a preferred product strategy
Hear how provider engagement, financial transparency, and P&T committee support helped drive adoption.
Learn how a phased implementation approach increased market share while improving financial performance.
08:11 Lessons learned from implementation
Explore the operational considerations that support successful implementation, from inventory management to prior authorizations.
Learning why collaboration with physicians, nurses, office staff, and billing teams is essential to long term success.
10:57 Key takeaways
Review the core elements of a successful botulinum toxin stewardship strategy.
Learn how multidisciplinary collaboration can improve value while maintaining high quality patient care.

Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed
13 min
June 30From clinician to executive: Developing pharmacy’s next leaders
As health systems grow more complex and executive expectations continue to expand, organizations must develop the next generation of pharmacy leaders. Host Carolyn Liptak is joined by Dr. Bonnie Levin and Dr. Cedric Terrell to discuss the growing pharmacy leadership pipeline challenge, the skills today's leaders need to succeed, and practical ways to identify and develop the next generation of pharmacy executives.

Guests:
Bonnie Levin, PharmD, MBA, FASHP
VP, Pharmacy Services
Medstar Health

Cedric Terrell, PharmD, MHA
SVP & Chief Pharmacy Officer
Pharmacy Enterprise Services
CommonSpirit Health

Host: 
Carolyn Liptak, MBA, BS Pharm
Pharmacy Executive Director, Regulatory Compliance
Vizient Center for Pharmacy Practice Excellence

Show Notes:
00:54 - The Pharmacy Leadership Pipeline
Why healthsystems are facing a shortage of pharmacy leaders.
The impact of retirements, workforce changes, and succession planning challenges.
How evolving expectations are reshaping leadership roles as pharmacy creates "a table that others want to sit at."
02:21 - The Modern Pharmacy Executive
How pharmacy leadership has changed over the last several years.
Why leaders now oversee larger, more complex healthcare enterprises.
Why today's leaders must think like pharmacy business executives, not just department directors.
03:31 - Skills Every Future Leader Needs
The growing importance of financial stewardship and business acumen.
Why strategic thinking is just as valuable as clinical expertise.
How pharmacy leaders create value through operations, finance, and innovation.
04:46 - Identifying Emerging Leaders
What makes an informal leader stand out, from raising their hand to offering solutions instead of problems.
Why leadership is a behavior, not a position.
The importance of mentoring future leaders and exposing them to experiences beyond their own department.
06:06 - Preparing the Next Generation
Where pharmacy education and leadership development are falling short.
Why financial literacy, budgeting, and operational knowledge are essential leadership skills.
How early exposure to business decisions helps future leaders build confidence.
07:31 - Residency and Real World Experience
The value residency programs provide in developing clinical expertise.
Why practical business experience is equally important for future executives.
How mentorship and cross functional learning prepare pharmacists for broader leadership roles.
09:16 - Moving Into Executive Leadership
How clinically trained pharmacists can expand into enterprise leadership.
Bonnie shares why saying yes to leading behavioral health became one of the most valuable experiences of her career.
Why leaders should seek opportunities that stretch their skills beyond pharmacy.
11:03 - Career Growth Through Opportunity
Why saying yes to unfamiliar challenges accelerates leadership development.
Expanding experience into areas like ambulatory care, payer strategy, imaging, and laboratory services.
Cedric explains why creating opportunities is more valuable than waiting for them to appear.
12:07 - Leadership Advice
Bonnie shares the quote that shaped her leadership philosophy.
Cedric reflects on advice from his mentor to prepare today for the role you want three to five years from now.
Why successful leaders stay curious and become comfortable making decisions with uncertainty.
13:58 - Looking Ahead
Why today's pharmacy leaders are optimistic about the future.
The value of innovation, persistence, collaboration, and strong professional relationships.
Final reflections on building the next generation of pharmacy executives through mentorship, curiosity, and continuous learning.

Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed
16 min
June 16Peeling back the layers of learning in residency programs
What happens when learners teach learners? Layered learning is a teaching model that brings pharmacy students, residents, and preceptors together in a collaborative learning environment. Our host Carolyn Liptak is joined by Dr. Sarah Eggers Russell, PharmD, BCACP, CPP of UNC Health REX and Dr. Kimberly James, PharmD of UF Health to discuss how layered learning works in pharmacy residency programs and why it continues to gain traction across healthcare settings. They share perspectives from their own programs and discuss what it takes to create meaningful learning experiences for learners at every stage of training.

Guest Speakers:
Dr. Sarah Eggers Russell, PharmD, BCACP, CPP
UNC Health REX

Dr. Kimberly James, PharmD
UF Health

Host: 
Carolyn Liptak, MBA, BS Pharm
Pharmacy Executive Director, Regulatory Compliance
Vizient Center for Pharmacy Practice Excellence

Show Notes:
00:05 - What Is Layered Learning?
Definition of layered learning and its role in pharmacy education
How teaching, mentorship, and patient care occur simultaneously
Benefits for learners, preceptors, and patients
01:08 - Residency Program Overviews
UNC Health Rex ambulatory care residency program
UF Health pediatric pharmacy residency program
Opportunities for students, residents, and advanced learners across diverse practice settings
02:22 - How Layered Learning Works in Practice
Senior learners mentoring junior learners under pharmacist supervision
Developing teaching skills and professional behaviors
Expanding direct patient care opportunities while supporting preceptor workloads
03:33 - Defining Roles and Responsibilities
Setting expectations before the rotation begins
Assessing learner readiness for teaching responsibilities
Creating structured orientation processes for all learners
Providing feedback and evaluation opportunities for resident preceptors
05:55 - Adapting to Different Learning Styles
Tailoring rotations to individual learner needs
Gradually increasing clinical responsibilities
Using regular feedback sessions and midpoint evaluations
Building confidence through progressive independence
08:20 - Building Successful Layered Learning Experiences
Differences between primary and co precepting models
Leveraging learners to expand patient access and clinical services
Using shared precepting across diverse practice environments
Creating opportunities for leadership and teaching development
10:42 - Keeping Learners Engaged in Ambulatory Care
Managing clinic schedules and patient encounters
Evidence based patient case presentations
Topic discussions, drug information requests, and interdisciplinary shadowing opportunities
Exposure to diagnostic testing and specialty practice areas
12:13 - Structuring Layered Learning in the Inpatient Setting
Working across multiple specialty consult services
Presenting to interdisciplinary healthcare teams
Shadowing opportunities with nursing and other disciplines
Using projects to improve patient care and learner engagement
13:39 - Advice for First Time Preceptors
Maintaining flexibility and adaptability
Meeting learners where they are in their development
Keeping communication open through regular check ins
Encouraging learners to embrace new challenges and teaching opportunities
14:51 - The Lasting Impact of Layered Learning
Benefits for junior learners, advanced learners, and preceptors
Strengthening interdisciplinary collaboration
Increasing awareness of pharmacy residency programs
Bringing fresh perspectives and new ideas into clinical practice
16:34 - Resources and What's Next
ASHP Guide for Best Practices of Layered Learning
Upcoming Vizient Layered Learning Toolkit currently in development

Links and Resources:
Residency Guide Best Practices for Resident Engagement in LLM

Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed
18 min
May 26Healthcare without walls: The growth of consumer - driven care
Direct-to-consumer healthcare is changing how patients engage with care, driven by growing demand for convenience, accessibility, and personalized experiences. VerifiedRx host Stacy Lauderdale is joined by Emily Fitt, Hailey Mulliner, and Heather Pace to discuss the continued rise of telehealth and direct-to-consumer healthcare platforms, the areas experiencing the most growth, and what these evolving models may mean for patients, providers, and health systems in the future.

Guest Speakers:
Emily Fitt, MHA, MPH
Senior Associate, Sg2 Intelligence
Vizient, Inc.

Hailey Mulliner, MS-HSM
Senior Director, Sg2 Intelligence
Vizient, Inc.

Heather Pace, Pharm.D.
Senior Clinical Manager, Ambulatory
Vizient, Inc.

Host:
Stacy Lauderdale, Pharm.D., BCPS
AVP, Evidence-Based Medicine
Vizient

Show Notes:
(00:52) The panel discusses where direct-to-consumer healthcare has gained the most traction, including:
Men’s reproductive health
Women’s contraceptives
Dermatology and acne care
Behavioral health
GLP-1 and obesity management
(01:59) Heather explains how GLP-1 medication shortages fueled growth in compounded obesity medications and expanded telehealth services.
(02:47) Hailey shares insights from SG2 consumer surveys, emphasizing how patients increasingly want customizable, convenient healthcare experiences like other consumer industries.
(03:26) The group explores future expansion areas for direct-to-consumer healthcare, including:
Cardiovascular disease management
Type 2 diabetes
Orthopedic care
Cardiometabolic disease monitoring
(04:31) Discussion shifts to the benefits and drawbacks for patients, including:
Increased convenience and access
More comfortable treatment environments
Greater patient empowerment
Risks of fragmented care and disconnected treatment plans
(06:07) Emily outlines concerns for health systems, including:
Increased emergency department utilization
Lack of coordinated care
Medication management gaps
Challenges identifying medications prescribed outside the health system
(07:03) Heather discusses medication stewardship concerns, particularly as weight loss impacts management of other chronic conditions like hypertension.
(07:29) The panel highlights operational challenges for hospitals and procedural teams when patients fail to disclose GLP-1 medications prior to surgeries or colonoscopies.
(07:58) The conversation turns to how direct-to-consumer healthcare is permanently changing consumer expectations around convenience and accessibility.
(08:36) The panel debates whether health systems should compete with direct-to-consumer companies or pursue partnership strategies.
(09:51) Emily discusses how health systems can differentiate themselves by offering the full continuum of care that virtual only providers cannot.
(10:20) Heather Pace emphasizes the importance of partnerships between health systems and direct-to-consumer platforms to improve access while maintaining coordinated care.
(10:55) The group discusses emerging partnerships in the marketplace, including collaborations between pharmaceutical manufacturers and direct-to-consumer platforms.
(12:14)Workforce challenges are explored, including:
Competition for clinicians
Provider burnout
Flexibility offered by virtual care employers
(13:17) The panel examines future trends involving AI, including patients using AI to interpret labs and emerging AI-assisted prescribing models in behavioral health.
(14:24) Closing thoughts on how direct-to-consumer healthcare is reshaping patient expectations and forcing health systems to rethink care delivery models.

Subscribe Today!
Apple Podcasts
Spotify
YouTube
RSS Feed
16 min

About VerifiedRx

From the publisher's feed

Delivering short doses of insight for hospitals’ frontline pharmacy professionals, the Vizient pharmacy team brings together experts to verify best practices for navigating today’s pharmacy practice…

Share VerifiedRx

Sign up to save your podcasts

VerifiedRx

VerifiedRx episodes

About VerifiedRx

More shows like VerifiedRx

Freakonomics Radio

The Daily

340B Insight

The Headlines